SGMO logo

Sangamo Therapeutics (SGMO) Operating Profit

Annual Operating Profit

-$118.99 M
+$82.29 M+40.88%

31 December 2023

SGMO Operating Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Operating Profit

$10.63 M
+$46.54 M+129.60%

30 September 2024

SGMO Quarterly Operating Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Operating Profit

-$134.22 M
+$72.24 M+34.99%

30 September 2024

SGMO TTM Operating Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

SGMO Operating Profit Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+40.9%+117.3%-19.2%
3 y3 years+8.2%+122.0%+28.2%
5 y5 years-54.2%+136.3%-5.3%

SGMO Operating Profit High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 yearsat high+40.9%-86.1%+114.7%-69.0%+44.7%
5 y5 years-54.2%+40.9%-86.1%+114.7%-69.0%+44.7%
alltimeall time<-9999.0%+40.9%-86.1%+114.7%-4714.2%+44.7%

Sangamo Therapeutics Operating Profit History

DateAnnualQuarterlyTTM
Sept 2024
-
$10.63 M(-129.6%)
-$134.22 M(-35.0%)
June 2024
-
-$35.91 M(-23.9%)
-$206.46 M(-15.0%)
Mar 2024
-
-$47.18 M(-23.6%)
-$242.77 M(+104.0%)
Dec 2023
-$118.99 M(-40.9%)
-$61.76 M(+0.2%)
-$118.99 M(+5.7%)
Sept 2023
-
-$61.61 M(-14.7%)
-$112.62 M(+6.3%)
June 2023
-
-$72.22 M(-194.3%)
-$105.91 M(+33.4%)
Mar 2023
-
$76.61 M(-238.3%)
-$79.42 M(-60.5%)
Dec 2022
-$201.28 M(+9.8%)
-$55.39 M(+0.9%)
-$201.28 M(+8.3%)
Sept 2022
-
-$54.89 M(+20.0%)
-$185.79 M(+3.6%)
June 2022
-
-$45.73 M(+1.0%)
-$179.33 M(-1.6%)
Mar 2022
-
-$45.26 M(+13.4%)
-$182.30 M(-0.6%)
Dec 2021
-$183.34 M(+41.5%)
-$39.90 M(-17.6%)
-$183.34 M(-1.9%)
Sept 2021
-
-$48.44 M(-0.5%)
-$186.87 M(+31.5%)
June 2021
-
-$48.70 M(+5.2%)
-$142.13 M(+8.2%)
Mar 2021
-
-$46.30 M(+6.6%)
-$131.33 M(+1.4%)
Dec 2020
-$129.55 M(+23.2%)
-$43.43 M(+1073.5%)
-$129.55 M(+53.0%)
Sept 2020
-
-$3.70 M(-90.2%)
-$84.65 M(-23.2%)
June 2020
-
-$37.90 M(-14.9%)
-$110.20 M(+4.2%)
Mar 2020
-
-$44.52 M(-3130.8%)
-$105.81 M(+0.6%)
Dec 2019
-$105.18 M(+36.3%)
$1.47 M(-105.0%)
-$105.18 M(-17.5%)
Sept 2019
-
-$29.25 M(-12.7%)
-$127.42 M(+11.4%)
June 2019
-
-$33.50 M(-23.7%)
-$114.41 M(+14.4%)
Mar 2019
-
-$43.90 M(+111.3%)
-$100.05 M(+29.7%)
Dec 2018
-$77.15 M(+36.9%)
-$20.77 M(+27.9%)
-$77.15 M(+10.0%)
Sept 2018
-
-$16.24 M(-15.1%)
-$70.14 M(+4.8%)
June 2018
-
-$19.14 M(-8.8%)
-$66.94 M(+10.5%)
Mar 2018
-
-$21.00 M(+52.5%)
-$60.57 M(+7.5%)
Dec 2017
-$56.36 M(-22.3%)
-$13.77 M(+5.6%)
-$56.36 M(+7.5%)
Sept 2017
-
-$13.04 M(+2.1%)
-$52.42 M(-10.5%)
June 2017
-
-$12.77 M(-24.0%)
-$58.60 M(-19.4%)
Mar 2017
-
-$16.79 M(+70.8%)
-$72.67 M(+0.2%)
Dec 2016
-$72.56 M(+54.9%)
-$9.83 M(-48.8%)
-$72.56 M(-7.5%)
Sept 2016
-
-$19.21 M(-28.4%)
-$78.40 M(+9.1%)
June 2016
-
-$26.84 M(+60.9%)
-$71.88 M(+25.4%)
Mar 2016
-
-$16.68 M(+6.4%)
-$57.32 M(+22.3%)
Dec 2015
-$46.86 M(+75.0%)
-$15.67 M(+23.6%)
-$46.86 M(+31.4%)
Sept 2015
-
-$12.69 M(+3.3%)
-$35.65 M(+16.4%)
June 2015
-
-$12.28 M(+97.3%)
-$30.62 M(+20.6%)
Mar 2015
-
-$6.22 M(+39.2%)
-$25.39 M(-5.2%)
Dec 2014
-$26.78 M(+0.3%)
-$4.47 M(-41.6%)
-$26.78 M(-12.2%)
Sept 2014
-
-$7.65 M(+8.6%)
-$30.49 M(+5.2%)
June 2014
-
-$7.05 M(-7.4%)
-$28.99 M(+5.8%)
Mar 2014
-
-$7.61 M(-6.9%)
-$27.41 M(+2.6%)
Dec 2013
-$26.71 M(+20.3%)
-$8.17 M(+32.7%)
-$26.71 M(+21.9%)
Sept 2013
-
-$6.16 M(+12.6%)
-$21.90 M(+1.7%)
June 2013
-
-$5.47 M(-20.8%)
-$21.54 M(-1.3%)
Mar 2013
-
-$6.91 M(+105.0%)
-$21.82 M(-1.7%)
Dec 2012
-$22.20 M(-38.0%)
-$3.37 M(-41.9%)
-$22.20 M(-11.9%)
Sept 2012
-
-$5.80 M(+1.0%)
-$25.19 M(-13.0%)
June 2012
-
-$5.74 M(-21.1%)
-$28.97 M(-13.5%)
Mar 2012
-
-$7.28 M(+14.4%)
-$33.50 M(-6.5%)
DateAnnualQuarterlyTTM
Dec 2011
-$35.82 M(+43.7%)
-$6.37 M(-33.5%)
-$35.82 M(-5.2%)
Sept 2011
-
-$9.57 M(-6.9%)
-$37.79 M(+2.3%)
June 2011
-
-$10.28 M(+7.1%)
-$36.94 M(+21.0%)
Mar 2011
-
-$9.60 M(+15.1%)
-$30.53 M(+22.5%)
Dec 2010
-$24.93 M(+28.5%)
-$8.34 M(-4.3%)
-$24.93 M(+31.2%)
Sept 2010
-
-$8.71 M(+124.7%)
-$19.01 M(+25.9%)
June 2010
-
-$3.88 M(-3.1%)
-$15.10 M(-7.8%)
Mar 2010
-
-$4.00 M(+65.8%)
-$16.38 M(-15.6%)
Dec 2009
-$19.40 M(-23.5%)
-$2.42 M(-49.7%)
-$19.40 M(+1.1%)
Sept 2009
-
-$4.80 M(-6.9%)
-$19.19 M(-7.6%)
June 2009
-
-$5.16 M(-26.6%)
-$20.76 M(-12.0%)
Mar 2009
-
-$7.03 M(+219.5%)
-$23.59 M(-7.0%)
Dec 2008
-$25.38 M(+2.4%)
-$2.20 M(-65.5%)
-$25.38 M(-17.6%)
Sept 2008
-
-$6.38 M(-20.1%)
-$30.79 M(+3.6%)
June 2008
-
-$7.99 M(-9.3%)
-$29.72 M(+7.8%)
Mar 2008
-
-$8.81 M(+15.8%)
-$27.57 M(+11.3%)
Dec 2007
-$24.77 M(+19.5%)
-$7.61 M(+43.0%)
-$24.77 M(-8.2%)
Sept 2007
-
-$5.32 M(-8.9%)
-$26.97 M(+6.6%)
June 2007
-
-$5.84 M(-2.8%)
-$25.29 M(+7.5%)
Mar 2007
-
-$6.01 M(-38.7%)
-$23.53 M(+13.5%)
Dec 2006
-$20.73 M(+50.8%)
-$9.81 M(+169.2%)
-$20.73 M(+49.7%)
Sept 2006
-
-$3.64 M(-10.5%)
-$13.84 M(-1.1%)
June 2006
-
-$4.07 M(+26.9%)
-$13.99 M(+4.6%)
Mar 2006
-
-$3.21 M(+9.9%)
-$13.38 M(-2.7%)
Dec 2005
-$13.75 M(-6.2%)
-$2.92 M(-23.0%)
-$13.75 M(-3.4%)
Sept 2005
-
-$3.79 M(+9.7%)
-$14.23 M(-5.8%)
June 2005
-
-$3.46 M(-3.5%)
-$15.11 M(+83.0%)
Mar 2005
-
-$3.58 M(+5.3%)
-$8.26 M(+5.1%)
Dec 2004
-$14.65 M(+24.5%)
-$3.40 M(-27.3%)
-$7.86 M(+21.1%)
Sept 2004
-
-$4.67 M(-237.6%)
-$6.49 M(+35.8%)
June 2004
-
$3.40 M(-206.9%)
-$4.78 M(-59.8%)
Mar 2004
-
-$3.18 M(+56.7%)
-$11.88 M(+0.9%)
Dec 2003
-$11.77 M(-62.3%)
-$2.03 M(-31.6%)
-$11.77 M(+9.2%)
Sept 2003
-
-$2.97 M(-19.9%)
-$10.78 M(-63.1%)
June 2003
-
-$3.70 M(+20.6%)
-$29.23 M(-0.9%)
Mar 2003
-
-$3.07 M(+196.7%)
-$29.50 M(-5.4%)
Dec 2002
-$31.19 M(+102.8%)
-$1.03 M(-95.2%)
-$31.19 M(-8.6%)
Sept 2002
-
-$21.42 M(+438.6%)
-$34.13 M(+91.3%)
June 2002
-
-$3.98 M(-16.5%)
-$17.84 M(+4.2%)
Mar 2002
-
-$4.76 M(+19.8%)
-$17.12 M(+11.3%)
Dec 2001
-$15.38 M(+23.2%)
-$3.97 M(-22.5%)
-$15.38 M(+0.6%)
Sept 2001
-
-$5.13 M(+57.5%)
-$15.28 M(+15.3%)
June 2001
-
-$3.25 M(+7.7%)
-$13.26 M(+4.3%)
Mar 2001
-
-$3.02 M(-22.0%)
-$12.72 M(+1.9%)
Dec 2000
-$12.48 M(+220.1%)
-$3.88 M(+24.9%)
-$12.48 M(+45.1%)
Sept 2000
-
-$3.10 M(+14.5%)
-$8.61 M(+56.5%)
June 2000
-
-$2.71 M(-2.7%)
-$5.50 M(+97.3%)
Mar 2000
-
-$2.79 M
-$2.79 M
Dec 1999
-$3.90 M(+12.8%)
-
-
Dec 1998
-$3.46 M(+157.1%)
-
-
Dec 1997
-$1.34 M(+323.0%)
-
-
Dec 1996
-$318.00 K
-
-

FAQ

  • What is Sangamo Therapeutics annual operaing income?
  • What is the all time high annual operating profit for Sangamo Therapeutics?
  • What is Sangamo Therapeutics annual operating profit year-on-year change?
  • What is Sangamo Therapeutics quarterly operating income?
  • What is the all time high quarterly operating profit for Sangamo Therapeutics?
  • What is Sangamo Therapeutics quarterly operating profit year-on-year change?
  • What is Sangamo Therapeutics TTM operating income?
  • What is the all time high TTM operating profit for Sangamo Therapeutics?
  • What is Sangamo Therapeutics TTM operating profit year-on-year change?

What is Sangamo Therapeutics annual operaing income?

The current annual operating profit of SGMO is -$118.99 M

What is the all time high annual operating profit for Sangamo Therapeutics?

Sangamo Therapeutics all-time high annual operaing income is -$318.00 K

What is Sangamo Therapeutics annual operating profit year-on-year change?

Over the past year, SGMO annual operaing income has changed by +$82.29 M (+40.88%)

What is Sangamo Therapeutics quarterly operating income?

The current quarterly operating profit of SGMO is $10.63 M

What is the all time high quarterly operating profit for Sangamo Therapeutics?

Sangamo Therapeutics all-time high quarterly operating income is $76.61 M

What is Sangamo Therapeutics quarterly operating profit year-on-year change?

Over the past year, SGMO quarterly operating income has changed by +$72.24 M (+117.26%)

What is Sangamo Therapeutics TTM operating income?

The current TTM operating profit of SGMO is -$134.22 M

What is the all time high TTM operating profit for Sangamo Therapeutics?

Sangamo Therapeutics all-time high TTM operating income is -$2.79 M

What is Sangamo Therapeutics TTM operating profit year-on-year change?

Over the past year, SGMO TTM operating income has changed by -$21.60 M (-19.18%)